comparemela.com

Agapitos Patakas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Agilent Wins Two Scientists Choice Awards for Drug Discovery and Development Products -February 08, 2024 at 08:07 am EST

Agilent Technologies Inc. announced today that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development.

United statesBiotek biospaAgapitos patakasTodd christianAgilent cell analysis divisionAgilent technologies incAgilent technologiesDrug discovery development webinarInternational conferenceDrug discovery development productBest new drug discoveryDevelopment productDrug discoveryDevelopment webinarScreening modelReal time cell analyzer

Agilent Wins Two Scientists Choice Awards for Drug Discovery and Development Products

08.02.2024 - Agilent Technologies Inc. (NYSE: A) announced today that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year. These accolades highlight .

United statesAgapitos patakasTodd christianAgilent technologiesInternational conferenceDrug discovery development webinarAgilent technologies incAgilent cell analysis divisionDrug discoveryDevelopment webinarChief scientific officerReal time cell analyzerAgilent novocyte flow cytometerCell analysisScientist choice awardsAgilent technologies stock

SLAS2024: Drug Discovery & Development winners announced

Meet the winners of the 2024 Drug Discovery & Development Scientists Choice Awards which were announced at SLAS 2024

Axion biosystemsPeter wolffAgapitos patakasBiotek biospaDrug discovery development video of the yearGroup leaderTumoroid screening labDrug discovery development scientist choiceUniversity of antwerpAgilent technologiesInternational conferenceAzenta life sciencesDrug discovery development applicationDrug discovery development webinarDrug discovery development email of the yearDrug discovery development product

Modeling the tumor microenvironment

Watch this on-demand webinar to learn about an in vitro T cell exhaustion model

Agapitos patakasExpert insightChief scientific officerAntibody analyticsModeling the tumor microenvironment selectscience immunologyImmune cell infiltrateN vitro cell based assay

Antibody Analytics Completes Multi-Million-GBP Investment From NorthEdge

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United kingdomJon pickeringSimone mastersonAndy upsallAgapitos patakasNorthedge manchesterAntibody analyticsUnited kingdom basedChief scientific officerLiam may

vimarsana © 2020. All Rights Reserved.